[PDF] Top 20 Role of antiplatelet therapy in ischemic stroke – a review

... Orally aspirin is administered once a day at different doses for prevention of stroke and myocardial infarction (19). Effect of aspirin on platelets is irreversible which causes inhibition of the lifespan of a ... See full document

... after ischemic stroke, but some studies demon- strate that cav-1 inhibits neural progenitor cells differentiation under normoxic and hypoxic conditions through the downregulation of VEGF ... See full document

... Evidence for a time course of bleeding risk is scarce. Post hoc analyses on data from CHARISMA showed that the excess risk of bleeding on aspirin plus clopidogrel was greatest in the first year and similar to aspirin ... See full document

... Provenance and peer review Not commissioned; externally peer reviewed. open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) ... See full document

... with ischemic stroke who are treated with warfarin or aspirin, large aortic plaques and especially those with complex morphology remained associated with an increased risk of recurrent stroke and ... See full document

... three antiplatelet agents (typically aspirin, clopidogrel and an intravenous GPIIb/IIIa recep- tor antagonist) thereby supporting guidelines promoting this ...triple antiplatelet therapy for ... See full document

... Ischemic stroke causes the depletion of energy and induce excitotoxicity and neuroinflammation in the brain that results from thrombotic ...this review, the authors present an overview of the ... See full document

... cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well ...systematic review analyzed published data on SPION (superparamagnetic iron ... See full document

... dual therapy is more effective at preventing recurrence than monotherapy for acute prophylaxis, then intensive therapy with triple antiplatelets (combined aspirin + clopidogrel + dipyrida- mole) may be ... See full document

... and stroke. However, a continued need for the development of new antiplatelet therapies exists as the risk for MI, stroke, and death, remain a persistent problem for individuals suf- fering from ... See full document

... had ischemic events, tran- sient ischemic attack, or ischemic stroke referable to the distribution of the affected vertebral artery were ...suffered ischemic symptoms despite use of ... See full document

... and Stroke in Patients With Atherosclerosis-Thrombolysis In Myocardial Infarction 50 (TRA 2°P-TIMI 50) investigated atherothrombotic events in patients with stable ...standard antiplatelet therapy ... See full document

... whereas ischemic events were more frequent when the treatment was in the subacute ...of antiplatelet therapy needed to achieve a platelet inhibition rate high enough to prevent ischemic ... See full document

... Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK. It provides access to anonymised data collated from completed and monitored clinical trials. Within VISTA, demographic data such as age, sex and ... See full document

... Significant reduction in death from cardio- vascular causes non-fatal MI or non-fatal stroke  Pharmacokinetics: Prasugrel is a pro-drug and its anti-platelet activity is exhibited by its active metabolite. The ... See full document

... following ischemic stroke among adults aged ⱖ 65 ...first ischemic stroke during 1989 to 2001 among Cardiovascular Health Study ...recurrent stroke and 59.3/1,000 for CHD. After the ... See full document

... with antiplatelet agents and SICH ...using antiplatelet drugs prior to rt-PA thrombolysis, despite a strong relationship between this antiplatelet therapy and SICH ...6,000 stroke ... See full document

... A total of 99 consecutive patients with AF underwent successful LAA occlusion in our hospital from January 1, 2015 to March 31, 2017. Preoperative evaluation included clinical symptoms, AF lasting time, history of ... See full document

... Mrs K.M., an 84-year-old white woman who is known to you, comes in today for a refill of pantoprazole, which was started 4 weeks ago during a hospital admission for a stroke. The discharge summary in her chart ... See full document

... antithrombotic therapy involves the use of anticoagulants, antiplatelets given either as monotherapy or in combination for the prevention of thrombotic ...this therapy is ...single therapy or during ... See full document